These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 4358536)

  • 21. In vitro culture of cloned hamster melanoma cells containing R-type virus.
    Epstein WL; Fukuyama K
    Cancer Res; 1973 Apr; 33(4):825-31. PubMed ID: 4735239
    [No Abstract]   [Full Text] [Related]  

  • 22. Induction of partial immunologic tolerance in rats and progressive loss of cellular antigenicity in Gross virus lymphoma.
    Ioachim HL; Keller SE; Dorsett BH; Pearse A
    J Exp Med; 1974 Jun; 139(6):1382-94. PubMed ID: 4208416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tum- variants and the detection of tumor-specific transplantation antigens on spontaneous mouse tumors.
    Boon T; van Pel A; Uyttenhove C; Marchand M; Lambotte P
    Behring Inst Mitt; 1984 May; (74):209-13. PubMed ID: 6332616
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of the effect on allograft response of allogeneic and xenogeneic antisera in mice.
    Hilgert I; Pokorná Z; Kristofová H; Vlachov K
    Folia Biol (Praha); 1974; 20(2):116-24. PubMed ID: 4611803
    [No Abstract]   [Full Text] [Related]  

  • 25. Ultrastructural effects of thymidine analogs in melanosomes and virus activation in cloned hamster melanoma cells in culture.
    Epstein WL; Fukuyama K; Drake TE
    Yale J Biol Med; 1973 Dec; 46(5):471-81. PubMed ID: 4798393
    [No Abstract]   [Full Text] [Related]  

  • 26. Recognition and destruction of target cells by tumoricidal macrophages.
    Fidler IJ
    Isr J Med Sci; 1978 Jan; 14(1):177-91. PubMed ID: 204610
    [No Abstract]   [Full Text] [Related]  

  • 27. Tumorigenicity and antigenicity of mouse cells infected with Simian virus 40. I. Relationship of growth in vitro and in vivo in immunosuppressed and immunocompetent recipients.
    Wright PW; Smith HS; McCoy J
    J Natl Cancer Inst; 1973 Sep; 51(3):951-9. PubMed ID: 4355223
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumorigenicity, immunogenicity, and virus production in mouse melanoma cells treated with 5-bromodeoxyuridine.
    Silagi S; Beju D; Wrathall J; Deharven E
    Proc Natl Acad Sci U S A; 1972 Nov; 69(11):3443-7. PubMed ID: 4343973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of malignancy in interspecies Chinese hamster X mouse cell hybrids.
    Barski G; Blanchard MG; Youn JK; Leon B
    J Natl Cancer Inst; 1973 Sep; 51(3):781-92. PubMed ID: 4355218
    [No Abstract]   [Full Text] [Related]  

  • 30. Tumor immunology with particular reference to malignant melanoma.
    Maguire HC
    Int J Dermatol; 1975; 14(1):3-11. PubMed ID: 1092622
    [No Abstract]   [Full Text] [Related]  

  • 31. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cytotoxic immunity indices of melanoma B16 growth in mice].
    Korosteleva TA; Veresova OV
    Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunologic response to transplantable specific antigens in experimental tumors].
    Porwit-Bóbr Z
    Postepy Hig Med Dosw; 1971; 25(1):25-36. PubMed ID: 4932042
    [No Abstract]   [Full Text] [Related]  

  • 34. Serologically detectable MHC and tumor-associated antigens on B16 melanoma variants and humoral immunity in mice bearing these tumors.
    Baniyash M; Smorodinsky NI; Yaakubovicz M; Witz IP
    J Immunol; 1982 Sep; 129(3):1318-23. PubMed ID: 7108209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-cultivation of tumorigenic mouse melanoma cells with cells of a non-tumorigenic subclone inhibits plasminogen activator expression by the melanoma cells.
    Kyner D; Christman J; Acs G; Silagi S; Newcomb EW; Silverstein SC
    J Cell Physiol; 1978 May; 95(2):159-67. PubMed ID: 206566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attempted induction of tumor antigens in carcinogen-treated cells.
    Outzen HC; Andrews EJ; Basombrío MA; Litwin S; Prehn RT
    J Natl Cancer Inst; 1972 Nov; 49(5):1295-302. PubMed ID: 4568086
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of 5-bromodeoxyuridine (BUdR) on experimental metastasis.
    Zeidman I
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):827-35. PubMed ID: 4701271
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of immune factors on the motility of lymphoma cells.
    Cochran AJ; Klein E; Keissling R
    J Natl Cancer Inst; 1972 Jun; 48(6):1657-61. PubMed ID: 4560294
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor specific antigen appearance on normal cells during intermediate steps of viral carcinogenesis.
    Celada F
    Boll Ist Sieroter Milan; 1971; 50(3):176-84. PubMed ID: 5169543
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
    Kreider JW; Benjamin SA
    J Natl Cancer Inst; 1972 Nov; 49(5):1303-10. PubMed ID: 4568087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.